CR Pharma mandates BofA, CCB, Goldman as sponsors of HK IPO -IFR

March 2, 2016 8:58 AM

16 0

HONG KONG, March 2 China Resources Pharmaceutical Group, a unit of state-owned conglomerate China Resources Co Ltd., has mandated three banks as sponsors of a planned Hong Kong initial public offering of at least $1 billion, IFR reported on Wednesday, citing people close to the deal.

CR Pharma, as the company is called, tapped Bank of America Merrill Lynch, CCB International and Goldman Sachs to manage the deal, added IFR, a Thomson Reuters publication.

Also read: Highflying Chinese Oilman Is Tripped Up; a $9 Billion Russian Deal Is at Risk

Read more

To category page